Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
63.4K
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
596K
-
Shares change
-
+596K
-
Total reported value, excl. options
-
$106K
-
Value change
-
+$106K
-
Number of buys
-
10
-
Price
-
$0.18
Significant Holders of Helius Medical Technologies, Inc. - Common Stock, $0.001 par value per share (HSDT) as of Q2 2025
10 filings reported holding HSDT - Helius Medical Technologies, Inc. - Common Stock, $0.001 par value per share as of Q2 2025.
Helius Medical Technologies, Inc. - Common Stock, $0.001 par value per share (HSDT) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 596K shares
.
Largest 10 shareholders include Wealthspire Advisors, LLC (300K shares), Federation des caisses Desjardins du Quebec (200K shares), Baader Bank Aktiengesellschaft (50K shares), UBS Group AG (36.8K shares), Tower Research Capital LLC (TRC) (6.12K shares), IFP Advisors, Inc (3.33K shares), MORGAN STANLEY (123 shares), JPMORGAN CHASE & CO (53 shares), BANK OF AMERICA CORP /DE/ (4 shares), and American Capital Advisory, LLC (2 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.